Hydroxyzine alternatives if not eligible

Last Updated: January 2026

Finding the right mental health care shouldn’t feel like navigating a maze—yet for millions of Americans seeking help for ADHD, anxiety, depression, or insomnia, the telehealth landscape has become increasingly complex. Following high-profile regulatory actions, provider shutdowns, and dramatic policy changes over the past few years, patients are left wondering: Which online mental health platforms are still operating? Which ones actually prescribe the medications I need? And who can I trust?

If you’re researching telehealth mental health services in 2026, you’ve likely encountered confusing information about providers like Cerebral, Done, Brightside, Talkiatry, and others. This comprehensive guide cuts through the confusion with up-to-date information on what each major platform offers, what medications they will (and won’t) prescribe, pricing transparency, and how to choose the right provider for your specific needs.

Whether you’re seeking ADHD treatment, anxiety management, depression care, or help with insomnia or other conditions, understanding your telehealth options has never been more important—or more complicated.

The Telehealth Mental Health Landscape Has Changed Dramatically

The COVID-19 pandemic accelerated telehealth adoption at an unprecedented pace. Mental health startups proliferated, offering everything from quick ADHD evaluations to on-demand therapy. By 2022, however, concerns about prescription practices—particularly around controlled substances like Adderall and Xanax—triggered regulatory scrutiny that reshaped the entire industry.

Key developments that changed everything:

• May 2022: Cerebral, once a telehealth giant, stopped prescribing ADHD stimulants to new patients following investigations into its prescribing practices
• Mid-2022: Ahead (HelloAhead) shut down operations entirely due to financial and operational challenges
• June 2024: Done Global’s top executives were criminally indicted by the Department of Justice for allegedly operating an illegal ADHD drug distribution scheme—a first-of-its-kind prosecution
• November 2024: Cerebral settled with the DOJ, paying $3.6 million in fines for unauthorized distribution of controlled substances
• Throughout 2024-2025: The FDA cracked down on compounded weight-loss medication marketing, issuing warnings to telehealth platforms including Hims & Hers

These events created a ‘trust deficit’ in telehealth mental health care. Patients who once relied on these services found themselves abruptly cut off from medications, scrambling to find new providers, or navigating insurance complexities they’d hoped to avoid.

The silver lining? Responsible telehealth providers are stepping up to fill the gaps—offering legitimate, comprehensive care that balances accessibility with clinical rigor and regulatory compliance.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding What You Really Need: Conditions, Medications & Treatment Approaches

Before comparing providers, it’s essential to understand what you’re seeking treatment for and what medication categories might be involved. Different platforms have vastly different policies about what they will and won’t prescribe.

Common Mental Health Conditions Treated via Telehealth

ADHD (Attention-Deficit/Hyperactivity Disorder)
Adult ADHD affects approximately 4-5% of the U.S. population. Treatment typically involves stimulant medications (like Adderall or Vyvanse) or non-stimulant alternatives (like Strattera or Wellbutrin), combined with behavioral strategies. ADHD medication access has become the most contentious issue in telehealth mental health care.

Anxiety Disorders
From generalized anxiety to panic disorder, anxiety conditions are commonly treated with SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), or therapy. Historically, benzodiazepines like Xanax were prescribed, but most telehealth platforms now avoid these controlled substances entirely.

Depression
Major depressive disorder and persistent depressive disorder are typically treated with antidepressants (SSRIs, SNRIs, or atypical antidepressants) and psychotherapy. Depression treatment is widely available across telehealth platforms since the primary medications aren’t controlled substances.

Insomnia & Sleep Disorders
While lifestyle changes and therapy are first-line treatments, some patients need medication. However, most telehealth providers won’t prescribe controlled sleep medications (like Ambien or Lunesta), instead offering alternatives like trazodone or melatonin.

PTSD, OCD, Bipolar Disorder & Other Conditions
These more complex conditions require specialized psychiatric care. Not all telehealth platforms have the clinical depth to manage these appropriately—it’s crucial to find providers with experienced psychiatrists who can handle nuanced treatment plans.

The Controlled Substance Reality: What Medications Are Hard to Get Online

Schedule II Stimulants (ADHD medications)
Adderall, Ritalin, Vyvanse, Concerta—these are the medications that triggered the telehealth reckoning. Due to their abuse potential and regulatory scrutiny, most direct-to-consumer telehealth platforms have stopped prescribing them entirely or never offered them. Only full-service psychiatric providers with robust compliance programs continue to prescribe stimulants when medically appropriate.

Benzodiazepines (anti-anxiety medications)
Xanax, Ativan, Klonopin, Valium—nearly all telehealth platforms refuse to prescribe these Schedule IV controlled substances due to addiction risks and regulatory concerns. Patients seeking these medications typically need traditional in-person psychiatry or specialized telepsychiatry services.

‘Z-drugs’ (sleep medications)
Ambien, Lunesta, Sonata—these Schedule IV sleep aids are similarly restricted or prohibited across telehealth platforms. Providers generally offer non-controlled sleep medication alternatives instead.

What IS readily available online:
SSRIs (Prozac, Zoloft, Lexapro), SNRIs (Effexor, Cymbalta), atypical antidepressants (Wellbutrin, Remeron), buspirone for anxiety, hydroxyzine, trazodone for sleep, and non-stimulant ADHD medications like Strattera.

Comprehensive Provider Comparison: Who’s Who in Telehealth Mental Health

The table below provides a detailed comparison of the major telehealth mental health platforms operating in 2026, including their current status, services, medication policies, geographic reach, pricing, and insurance acceptance.

Major Telehealth Mental Health Providers – 2026 Comparison

What This Comparison Reveals

The ADHD Treatment Gap
Only Talkiatry among the major platforms will prescribe ADHD stimulants—and they do so within an insurance-based, highly regulated psychiatric practice model. This leaves patients who need stimulant medication with limited telehealth options, creating an opportunity for responsible providers who can offer this care safely.

The ‘Safe Medication’ Focus
Most platforms have pivoted to offering only non-controlled medications. Brightside, for example, explicitly markets its use of ‘non-addictive’ medications, which appeals to some patients but excludes anyone needing ADHD treatment or certain anxiety medications.

Price vs. Access Trade-offs
Subscription models (Cerebral, Brightside) offer predictable pricing but can be expensive over time and inflexible. Insurance-based models (Talkiatry, traditional telehealth) offer lower out-of-pocket costs but may involve wait times, network limitations, and bureaucracy. Cash-pay à la carte models offer flexibility but require upfront payment.

The Convenience vs. Legitimacy Balance
The platforms that offered the ‘easiest’ access to controlled substances (Done, old Cerebral) are now defunct or severely restricted. Meanwhile, traditional telehealth giants (Teladoc, MDLive) don’t offer specialized mental health medication management at all. There’s a clear middle ground: accessible, affordable care that’s also clinically responsible.

State-by-State Availability in Priority Markets

Most telehealth providers now operate nationwide, but licensing and state regulations can affect service availability. Here’s availability in the six largest U.S. states by population:

Note: Done and Ahead are excluded as they’re no longer operational. All active major providers serve these key states, though Talkiatry operates in 43 states total (excludes some smaller-population states).

The Medication Policy Deep Dive: What You Can and Can’t Get

Understanding each provider’s medication policy is crucial before choosing a platform. Here’s what you need to know:

ADHD Stimulant Prescribing (Schedule II)

Who WILL prescribe:

• Talkiatry: Yes, with appropriate evaluation by board-certified psychiatrists following DEA guidelines

Who WON’T prescribe:

• Cerebral (stopped May 2022)
• Brightside (never offered; doesn’t treat ADHD)
• PlushCare (explicit policy exclusion)
• MDLive (policy exclusion)
• Teladoc (policy exclusion)
• Amwell (policy exclusion)
• Hims/Hers (focus on non-controlled medications)

Why it matters: If you have ADHD and benefit from stimulant medication, your telehealth options are extremely limited. Many patients have been forced back to in-person psychiatrists or have switched to non-stimulant alternatives (which may be less effective for them). This is where specialized telehealth psychiatric services that maintain proper compliance can fill a critical need.

Benzodiazepine Prescribing (Schedule IV)

Who MIGHT prescribe (rarely, when clinically necessary):

• Talkiatry: Psychiatrists can prescribe when appropriate for specific anxiety or panic disorders

Who WON’T prescribe:

• Essentially all other platforms explicitly exclude benzodiazepines

What this means: If you’re currently taking Xanax, Ativan, Klonopin, or similar medications, most telehealth platforms cannot continue your prescription. Talkiatry or traditional in-person care are your primary options.

Sleep Medication Prescribing (Schedule IV ‘Z-drugs’)

Current policies:

• Virtually no telehealth platforms prescribe Ambien, Lunesta, or similar controlled sleep medications
• Most offer alternatives like trazodone, hydroxyzine, or recommend cognitive behavioral therapy for insomnia (CBT-I)

Non-Controlled Medications (Widely Available)

These medications are readily prescribed across most telehealth mental health platforms:

• SSRIs: Prozac, Zoloft, Lexapro, Celexa, Paxil
• SNRIs: Effexor, Cymbalta, Pristiq
• Atypical antidepressants: Wellbutrin, Remeron, Trintellix
• Non-stimulant ADHD meds: Strattera, Qelbree, Intuniv
• Anxiety medications (non-controlled): Buspirone, hydroxyzine
• Sleep aids (non-controlled): Trazodone, doxepin, melatonin

The GLP-1 Weight Loss Wildcard

An interesting 2024-2025 development: some telehealth platforms now offer weight-loss medications, particularly GLP-1 agonists (Wegovy, Ozempic, Mounjaro). These aren’t controlled substances, so they’re easier to prescribe via telehealth.

Who offers weight loss medication:

• Hims/Hers: Launched GLP-1 weight loss programs
• PlushCare: Will prescribe for appropriate candidates
• Ro, Found, Calibrate: Specialized weight-loss telehealth companies

Who doesn’t:

• Most mental-health-focused platforms (Brightside, Cerebral, Talkiatry)
• Teladoc explicitly excludes GLP-1s for elective weight loss

This represents an expansion of telehealth into metabolic health—and it’s worth noting if you’re dealing with both mental health concerns and weight management issues.

Pricing Transparency: What You’ll Actually Pay

One of the biggest frustrations patients report about telehealth mental health care is unclear or unexpected pricing. Let’s break down the real costs:

Subscription Models (Monthly Fees)

Cerebral:

• Medication management only: $99/month
• Therapy + medication management: $365/month
• Initial evaluation: Included in first month

Brightside:

• Medication plan: $95/month
• Therapy + medication plan: $349/month
• No insurance billing for out-of-network plans

Hims/Hers:

• Medication management: $85/month
• Individual therapy sessions: $99/session (separate purchase)
• Cash-pay only (HSA/FSA eligible)

Pros of subscriptions: Predictable costs, unlimited messaging with providers
Cons of subscriptions: Pay even months you don’t need a visit, can be expensive long-term, difficult cancellation processes reported by some users

Pay-Per-Visit Models

Talkiatry:

• With insurance: Typically $25-50 copay
• Without insurance: $250-300 initial evaluation, $150-200 follow-ups
• Varies significantly by state and insurance plan

Teladoc:

• General medical: $75-95/visit
• Mental health initial consultation: $200+
• Often covered fully or partially by employer health plans

MDLive:

• Urgent care: $0-82/visit (often employer-covered)
• Psychiatry: $108-120/visit (cash price)

Amwell:

• Urgent care: $79/visit
• Psychiatry/therapy: $95-120/visit

PlushCare:

• Membership fee: $19.99/month
• Per-visit fee: $129 (includes prescription if needed)
• Insurance may cover visit costs

Pros of pay-per-visit: Only pay when you need care, often insurance compatible
Cons of pay-per-visit: Costs can add up with frequent visits, less provider continuity sometimes

Hidden Costs to Watch For

• Medication costs: Not included in platform fees (pharmacy costs vary widely)
• Lab work: If required, billed separately
• Surprise insurance issues: Some providers claim to take insurance but are out-of-network
• Cancellation fees: Some subscriptions difficult to cancel
• Follow-up frequency: Some conditions require monthly visits (adds up quickly)

Where Klarity Health Fits In

For patients seeking transparent, affordable pricing without long-term commitments, Klarity Health offers competitive pay-as-you-go rates:

• Initial psychiatric evaluation: $149
• Follow-up medication management visits: $59
• Prescription refill requests: $25

This à la carte pricing model costs significantly less than most subscription services over time, especially for patients with stable conditions who only need occasional check-ins. Plus, Klarity accepts both insurance (for those with coverage) and cash pay (for those who prefer or need to pay directly), providing flexibility that many platforms don’t offer.

What Patients Actually Say: Real Reviews & Pain Points

Beyond official policies and pricing, what matters most is the patient experience. Here’s what users report about major platforms:

Cerebral: Mixed Reviews, Trust Issues

Common complaints:

• Provider turnover (assigned to multiple different prescribers)
• Difficulty canceling subscriptions
• Slow customer service response
• Abrupt policy changes (especially the 2022 ADHD prescription halt)

Positive feedback:

• Easy initial signup process
• Affordable for basic depression/anxiety care
• Medication delivery coordination

Bottom line: Cerebral’s reputation hasn’t recovered from 2022’s controversies. While still operational, many patients report inconsistent care quality.

Done: Cautionary Tale

Before its 2024 shutdown, Done received increasingly negative reviews:

• 10-minute ‘evaluations’ felt rushed and superficial
• Difficulty reaching prescribers between visits
• Pharmacy issues (many pharmacies refused to fill Done prescriptions)
• Abrupt service disruptions

What happened: Federal prosecutors alleged Done’s business model prioritized volume over appropriate care, leading to its leaders’ indictment. A stark reminder that ‘too easy’ access can signal problematic practices.

Brightside: Polished But Limited

Strengths:

• Professional, well-designed platform
• Responsive customer service
• Clear about what they do and don’t offer

Limitations:

• Won’t treat ADHD at all (even with non-stimulants)
• No controlled medications whatsoever
• Expensive therapy + medication combo

Best for: Patients with depression or anxiety comfortable with SSRI/SNRI medications who want a polished digital experience and don’t need ADHD care.

Talkiatry: Quality Care, Insurance Complexity

Strengths:

• Board-certified psychiatrists (not nurse practitioners)
• Will prescribe full range of medications when appropriate
• Good for complex cases (bipolar, treatment-resistant depression)

Challenges:

• Insurance billing can be confusing
• Wait times for initial appointments (1-3 weeks in some states)
• Provider availability varies by location
• Some patients report surprise bills

Best for: Patients who need comprehensive psychiatric care, have insurance, and are willing to navigate some administrative complexity for quality providers.

General Telehealth (Teladoc, MDLive, Amwell): Convenient But Limited

Strengths:

• Often free/low-cost through employers
• Broad geographic availability
• Good for urgent care and general medical needs

Limitations:

• Not specialized in mental health
• Won’t prescribe controlled substances
• Inconsistent provider knowledge about psychiatric medications
• Limited continuity of care

Best for: Mild anxiety or depression, prescription refills for established medications, or initial consultations before deciding on specialized care.

Hims/Hers: Modern Wellness, Niche Focus

Strengths:

• Slick, user-friendly platform
• Transparent pricing
• Fast service
• Expanding condition coverage

Limitations:

• Cash-pay only (no insurance)
• Limited to less complex conditions
• More lifestyle-focused than clinical care

Best for: Younger adults comfortable with tech-forward, direct-to-consumer healthcare for straightforward conditions.

How to Choose the Right Telehealth Provider for Your Needs

With so many options (and limitations), here’s a decision framework:

If You Have ADHD and Need Stimulant Medication:

Best options:

1. Talkiatry (if in their coverage area and have insurance)
2. Specialized ADHD telepsychiatry services that maintain DEA compliance
3. Traditional in-person psychiatry (if telehealth options exhausted)

What to avoid:

• Platforms that explicitly won’t prescribe stimulants (Cerebral, Brightside, PlushCare, etc.)
• Any provider promising ‘easy’ or ‘fast’ stimulant prescriptions without thorough evaluation

Klarity Health advantage: As a specialized psychiatric telehealth service, Klarity offers ADHD evaluation and treatment (including appropriate stimulant prescriptions when clinically indicated) with faster appointment availability than insurance-based psychiatry and more rigorous clinical standards than the discount subscription services.

If You Have Anxiety or Depression (No Controlled Medication Needed):

Best options:

1. Brightside (if you want a polished platform and bundled therapy)
2. Cerebral (budget-conscious, medication-only)
3. Your employer’s telehealth benefit (Teladoc, MDLive if free)
4. Hims/Hers (if you prefer direct-to-consumer model)

What to look for:

• Provider credentials (prescribers should be psychiatrists, psychiatric nurse practitioners, or supervised PAs)
• Medication options (make sure they prescribe the category you’re interested in)
• Therapy availability (if you want combined treatment)

Klarity Health advantage: Offers both medication management and therapy referrals with transparent, competitive pricing—without locking you into expensive monthly subscriptions.

If You Have Multiple or Complex Conditions:

Best options:

1. Talkiatry (comprehensive psychiatric care)
2. Traditional in-person psychiatry
3. Hybrid care (telehealth for routine management, in-person for initial evaluation)

What to avoid:

• Direct-to-consumer platforms focused on single conditions
• Services that only offer nurse practitioner care for complex cases

What to look for:

• Board-certified psychiatrists (not just NPs)
• Experience with your specific conditions
• Willingness to coordinate with other providers

Klarity Health advantage: Providers experienced in managing co-occurring conditions (e.g., ADHD + anxiety, depression + insomnia) with coordinated treatment plans and medication adjustments as needed.

If Cost Is Your Primary Concern:

Best options:

1. Your employer’s telehealth benefit (often free)
2. In-network Talkiatry (if you have insurance)
3. Community mental health centers with telehealth
4. Sliding-scale providers

Cost-effective approach:

• Start with insurance-covered options first
• For out-of-pocket care, compare total annual costs (not just monthly fees)
• Consider frequency of visits needed (pay-per-visit vs. subscription math)

Klarity Health advantage: No monthly subscription means you only pay for services you use. Initial evaluation ($149) and follow-ups ($59) typically cost less over time than subscription services, especially for stable patients needing quarterly or less frequent visits.

If You Value Convenience and Speed:

Best options:

1. Hims/Hers (typically fastest for non-controlled medications)
2. PlushCare (primary care + mental health)
3. Your employer’s telehealth (often same-day appointments)

What to watch for:

• ‘Too fast’ can be a red flag (thorough evaluation takes time)
• Balance speed with quality
• Make sure convenience doesn’t compromise safety

Klarity Health advantage: Offers appointments typically within days (not weeks like insurance psychiatry) while maintaining thorough evaluation standards—the sweet spot between ‘too fast to be safe’ and ‘too slow to be helpful.’

Red Flags to Watch For in Any Telehealth Mental Health Provider

The Done and Cerebral situations taught important lessons. Watch for these warning signs:

🚩 Red Flag #1: Pressure to Start Medication Immediately

Legitimate providers take time to evaluate you thoroughly. Be wary of services that guarantee prescriptions or push specific medications.

🚩 Red Flag #2: Prescribing Controlled Substances Too Easily

If you can get Adderall or Xanax after a 15-minute video chat with minimal questions, that’s not good care—it’s a prescription mill that will likely face regulatory action.

🚩 Red Flag #3: Difficult-to-Cancel Subscriptions

If you can sign up in minutes but canceling requires multiple phone calls or emails, that’s predatory business practice.

🚩 Red Flag #4: Providers You Never Actually Meet

Some platforms route you through multiple providers without continuity. While provider changes happen, you should have a consistent prescriber who knows your history.

🚩 Red Flag #5: No Clear Prescriber Credentials

Your provider’s name, credentials (MD, DO, NP, PA), and license number should be easily accessible. If they’re hidden, ask why.

🚩 Red Flag #6: Aggressive Marketing Claims

Promises like ‘Get your ADHD medication in 24 hours!’ or ‘We definitely treat ADHD!’ (when others won’t) can signal problematic practices.

🚩 Red Flag #7: Poor Communication Between Visits

You should be able to reach your provider or their care team with questions. Radio silence between appointments is unacceptable.

✅ Green Flags to Look For:

• Thorough initial evaluation (45-60 minutes minimum)
• Clear treatment plans explained in detail
• Regular follow-ups required (especially for controlled substances)
• Transparent pricing with no hidden fees
• Easy access to provider credentials
• Responsive customer support
• Willingness to coordinate with other healthcare providers
• Clear policies about what they do and don’t prescribe

The Regulatory Landscape: What’s Changing in 2026 and Beyond

Understanding the regulatory environment helps explain why providers have different policies—and what might change:

The Ryan Haight Act Waiver (Extended Through December 2025)

During COVID, the DEA allowed telehealth prescribing of controlled substances without an initial in-person visit. This waiver has been extended multiple times but faces an uncertain future.

What this means:

• Currently, providers CAN prescribe controlled substances via telehealth
• After the waiver expires, an in-person visit may be required first
• Many providers stopped prescribing controlled substances anyway due to liability concerns

State-Level Regulations Vary Widely

Some states have additional restrictions:

• Prescription monitoring program requirements
• Specific telehealth evaluation standards
• Limits on out-of-state prescribers

For patients: Check whether your provider is licensed in your state of residence (they must be).

What Might Change in 2026-2027

Possible scenarios:

1. Status quo: Waiver extended again, current policies continue
2. Hybrid requirement: One in-person visit required, then telehealth allowed
3. Full restriction: Return to pre-COVID rules (in-person for all controlled substances)

What responsible providers are doing:

• Building partnerships with local clinics for hybrid care
• Focusing on conditions treatable with non-controlled medications
• Investing in compliance infrastructure
• Advocating for reasonable permanent telehealth policies

Klarity Health’s approach: Maintaining flexible care models that can adapt to regulatory changes while continuing to serve patients regardless of what rules emerge—including partnerships for in-person visits if required.

Special Considerations: Insurance, Privacy & Prescriptions

Insurance Coverage: The Complicated Reality

Platforms that bill insurance:

• Talkiatry (in-network with many plans)
• Brightside (accepts some plans)
• Traditional telehealth (Teladoc, MDLive, Amwell – often employer-sponsored)

Platforms that don’t:

• Hims/Hers (cash only, but HSA/FSA eligible)
• Cerebral (limited insurance; mostly cash)

Insurance complications to know:

• ‘Accepts insurance’ doesn’t mean they’re in-network
• Out-of-network providers may cost more than cash-pay options
• Mental health parity laws require equal coverage, but enforcement varies
• Some insurers won’t cover telehealth for mental health

Klarity Health’s insurance approach: Accepts major insurance plans for patients who have coverage, but also offers competitive cash-pay rates for those who don’t or prefer to pay directly. This ‘both/and’ approach maximizes access regardless of insurance status.

Privacy & Data Security

Mental health information is sensitive. Key questions to ask:

HIPAA compliance: All legitimate healthcare providers must follow HIPAA. Wellness apps may not.

Data sharing: Read the privacy policy. Some platforms share anonymized data with third parties.

Advertising tracking: Some services use your mental health information to target ads (check policies carefully).

Prescription records: Controlled substance prescriptions go into state monitoring databases (unavoidable by law).

Best practices:

• Use secure internet connections for video visits
• Be cautious about apps that want access to other health data
• Understand what happens to your data if you switch providers

Getting Your Prescriptions Filled

Pharmacy partnerships:

• Some platforms partner with specific pharmacies (often mail-order)
• Others send prescriptions to your pharmacy of choice
• Controlled substances typically can’t be mailed (must pick up in person)

Insurance and pharmacy benefits:

• Your telehealth provider and your pharmacy coverage are separate
• The platform may accept insurance but your medication might not be covered
• GoodRx or similar services can reduce costs for non-covered medications

Controlled substance complications:

• Some pharmacies won’t fill prescriptions from certain telehealth providers
• You may need to call ahead to confirm your pharmacy will fill the prescription
• DEA number and provider information must be complete

Klarity Health’s pharmacy approach: Works with your preferred pharmacy and helps navigate any insurance or filling complications, including backup options if your first-choice pharmacy has concerns.

The Future of Telehealth Mental Health: Where Is This All Going?

Despite recent turbulence, telehealth mental health care is here to stay. Here’s what’s likely to evolve:

Consolidation & Integration

Expect more mergers and acquisitions as smaller startups struggle and larger healthcare entities buy up successful platforms. Insurance companies and health systems will increasingly offer their own telehealth mental health services.

What this means for patients: More choices through insurers, but potentially less innovative care as corporate medicine dominates.

Hybrid Care Models

The future probably isn’t ‘all telehealth’ or ‘all in-person’—it’s both. Expect models where initial evaluations are in-person but follow-ups are virtual, or where prescribers coordinate with local therapists.

What this means for patients: More flexibility but potentially more coordination needed between providers.

Specialized Services

As general telehealth platforms avoid controlled substances, specialized services will fill niches:

• ADHD-focused telehealth with strict compliance
• Anxiety disorder specialists
• Addiction medicine (already growing via buprenorphine telehealth)
• Treatment-resistant depression programs

What this means for patients: Better condition-specific care but need to research provider quality carefully.

Technology Improvements

AI and automation will increasingly assist (but not replace) providers:

• Symptom tracking apps integrated with provider dashboards
• Automated medication reminders and refill coordination
• AI-assisted clinical decision support

What this means for patients: Potentially better care

Source:

• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Cerebral%20provides%20telehealth%20consultations%20for,from%20tiered%20monthly%20subscription%20plans
• https://finvsfin.com/hims-anxiety-reviews/#:~:text=Out%20of%20pocket%2C%20Hims%20will,99%20for%20each%20counseling%20session
• https://apnews.com/article/498cb907623565ee680b33b1367efb84#:~:text=Top%20executives%20of%20the%20California,executives%20of%20defrauding%20taxpayers%2C%20exacerbating
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=Halcyon%20Health%20and%20ADHD,Ahead%20shut%20down%20this%20year
• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Embattled%20telemental%20healthcare%20provider%20Cerebral,unauthorized%20distribution%20of%20controlled%20substances
• https://apnews.com/article/9c08db3481dcfd67c433fad1ae07d941#:~:text=The%20FDA%20has%20launched%20its,originals%2C%20which%20the%20FDA%20disputes
• https://www.teladochealth.com/info/prescription-policy#:~:text=pressure%20medication,well%20as%20Teladoc%20Health%20policy
• https://www.brightside.com/faqs/what-medications-do-we-prescribe/#:~:text=Note%3A%20Brightside%20does%20not%20prescribe,controlled%20substance%20in%20some%20states
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=substance%20prescriptions%20from%20Cerebral%20and,substance%20medications
• https://h-o-m-e.org/does-cerebral-prescribe-xanax/#:~:text=Cerebral%20takes%20a%20conservative%20approach,such%20as%20Xanax%20or%20Ativan